Company Filing History:
Years Active: 2012
Title: **Paritosh Dhawale: Innovator in Minimally Invasive Cardiac Procedures**
Introduction
Paritosh Dhawale, based in Martinsville, NJ, is an accomplished inventor known for his significant contributions to the field of minimally invasive medical procedures. His innovative approach to treating mitral valve regurgitation showcases the blend of medical expertise and engineering ingenuity.
Latest Patents
Dhawale holds a patent for a method and system aimed at plicating tissue during minimally invasive medical procedures for the treatment of mitral valve regurgitation. This patent describes a sophisticated system that reshapes the mitral valve annulus by performing plications on the annular or adjacent tissue, which are then secured using a retainer. The system includes four specialized devices: a crossing catheter with a prolapseable tip, a deflecting guide catheter for accurate positioning, a plication device for creating the necessary plications, and a 'C' shaped retainer designed to hold the plicated tissue in place. This innovative approach addresses the challenges associated with traditional surgical methods and enhances patient outcomes.
Career Highlights
Paritosh Dhawale currently works with Cordis Corporation, where he continues to innovate in the medical device sector. His focus on cardiac procedures emphasizes his dedication to advancing healthcare technology. His single patent reflects his commitment to developing practical solutions for complex medical issues faced by patients suffering from mitral valve regurgitation.
Collaborations
Throughout his career, Dhawale has collaborated with talented individuals such as Adam Groothuis and Matthew E Krever. These partnerships have fostered a collaborative environment that encourages shared knowledge and innovation, ultimately contributing to the field of minimally invasive medical techniques.
Conclusion
Paritosh Dhawale stands out as a notable inventor in the realm of medical technology. His pioneering patent enhances the effectiveness of treatment for mitral valve regurgitation while embodying the spirit of innovation. Through his work at Cordis Corporation and collaborative efforts with esteemed colleagues, Dhawale continues to impact the healthcare industry positively, paving the way for safer and more effective treatment options.